Authors:
MOHAMMAD RM
BECK FWJ
KATATO K
HAMDY N
WALL N
ALKATIB A
Citation: Rm. Mohammad et al., POTENTIATION OF 2-CHLORODEOXYADENOSINE ACTIVITY BY BRYOSTATIN-1 IN THE RESISTANT CHRONIC LYMPHOCYTIC-LEUKEMIA CELL-LINE (WSU-CLL) - ASSOCIATION WITH INCREASED RATIOS OF DCK 5'-NT AND BAX/BCL-2/, Biological chemistry, 379(10), 1998, pp. 1253-1261
Authors:
HAWKINS F
EPSTEIN S
HAMDY N
TESSER J
MALICE MP
DAIFOTIS AG
ESPINOSA D
Citation: F. Hawkins et al., DO DISEASE AND CONCOMITANT MEDICATIONS INFLUENCE THE EFFECT OF ALENDRONATE ON SPINE BMD IN PATIENTS RECEIVING GLUCOCORTICOIDS, Arthritis and rheumatism, 41(9), 1998, pp. 1616-1616
Authors:
SMETS Y
HAMDY N
PIJL J
RINGERS J
DEFIJTER J
LEMKES H
Citation: Y. Smets et al., OSTEOPOROSIS IN IDDM PATIENTS AFTER SUCCESSFUL SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION, Diabetes, 46, 1997, pp. 1484-1484
Authors:
LIMVARAPUSS C
MOHAMMAD RM
WALL N
HAMDY N
MEHRA V
PETTIT GR
ALKATIB A
Citation: C. Limvarapuss et al., A NEW TUBULIN POLYMERIZATION INHIBITOR, AURISTATIN PE, DOWN-REGULATESALTERED P53 AND INDUCES TUMOR-REGRESSION IN A HUMAN WALDENSTROMS MACROGLOBULINEMIA MODEL, Blood, 90(10), 1997, pp. 1458-1458
Authors:
MOHAMMAD RM
BECK FWJ
WALL N
HAMDY N
MENDPARA SD
LIU KZ
SCHULTZ CP
HANNOUDI GN
MANTSCH HH
ALKATIB A
Citation: Rm. Mohammad et al., THE ROLE OF BRYOSTATIN-1 IN 2-CDA RESISTANT B-CLL LINE - MECHANISM OFRESISTANCE AND RESPONSE, Blood, 90(10), 1997, pp. 2364-2364
Authors:
BHATIA K
SPANGLER G
GAIDANO G
HAMDY N
DALLAFAVERA R
MAGRATH L
Citation: K. Bhatia et al., MUTATIONS IN THE CODING REGION OF C-MYC OCCUR FREQUENTLY IN ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED LYMPHOMAS, Blood, 84(3), 1994, pp. 883-888
Authors:
BHATIA K
SPANGLER G
ADVANI S
KAMEL A
HAMDY N
IYER RS
APLAN P
MAGRATH IT
Citation: K. Bhatia et al., MOLECULAR CHARACTERIZATION OF SCL REARRANGEMENTS IN T-CELL ALL FROM INDIA AND EGYPT, International journal of oncology, 2(5), 1993, pp. 725-730